ASH 2013 Preview: Novel Immunotherapies Under Development For The ... The Myeloma Beacon ... then had their regulatory T cells removed via treatment of the patients with an antibody called Simulect (basiliximab), and three patients underwent transplantation using stem cells that had regulatory T cells removed in the laboratory prior to ... |
